Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.

Researchers devise strategies to improve checkpoint inhibitor therapy and predict patient response.

Surveillance Gaps: How Cancer Arises

A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

Jeffrey Weidner and Eric Niederkofler will discuss strategies for optimizing dose response assays.

LuZhe Sun will discuss TGFβ signaling during cancer progression and how researchers can target this pathway.

Arnold Levine will discuss his discovery of p53 and the evolution of the field since then, and Jon Chen will discuss the use of single-cell phosphoproteomics in identifying changes in key signaling networks, including p53.

A look at the molecular processes that may feed into the tumor-fighting effects of physical activity

Gene editing can knock out genes crucial to cervical tumor cells’ survival, researchers report.